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Malaria is a widespread infectious disease caused by the parasite Plasmodium. During pregnancy, malaria infection leads to a
range of complications that can affect both the mother and fetus, including stillbirth, infant mortality, and low birth weight. In
this study, we utilized a mouse model of placental malaria (PM) infection to determine the importance of the proteinMyD88 in
the host immune response to Plasmodium during pregnancy. Initially, we demonstrated that Plasmodium bergheiNK65GFP
adhered to placental tissue via chondroitin sulfate A and induced PM inmice with a C57BL/6 genetic background. To evaluate
the involvement of MyD88 in the pathology of PM, we performed a histopathological analysis of placentas obtained from
MyD88/ and wild-type (WT)mice following infection on the 19th gestational day. Our data demonstrated that the detrimen-
tal placental alterations observed in the infected mice were correlated with the expression of MyD88. Moreover, in the absence of
this protein, production of interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF-) was significantly reduced in the in-
fected mice. More importantly, in contrast to fetuses from infectedWTmice, which exhibited a reduction in body weight, the
fetuses from infectedMyD88/mice did not display significant weight loss compared to their noninfected littermates. In addi-
tion, we observed a decrement of maternal care associated with malaria infection, which was attenuated in theMyD88-deficient
mice. Collectively, the results of this study illustrate the pivotal importance of the MyD88 signaling pathway in the pathogenesis
of placental malaria, thus presenting new possibilities for targetingMyD88 in therapeutic interventions.
Malaria is still the world’s most threatening infectious diseasefound in tropical and subtropical areas and is transmitted
via the bites of mosquitoes that are infected with the parasite Plas-
modium. Following infection, the Plasmodium parasites multiply
in the liver and then infect red blood cells. The symptoms of ma-
laria often include fever, headache, and vomiting and typically
appear 10 to 15 days after the mosquito bite. If left untreated,
malaria can develop into a severe form of the disease (1). Plasmo-
dium infection during pregnancy has been implicated in a number
of pregnancy-related complications, such as spontaneous abor-
tion, intrauterine growth retardation, and low birth weight, which
are known risk factors for neonatal mortality (2, 3).
Many of the complications of pregnancy caused by Plasmo-
dium infection are related to the accumulation of infected red
blood cells (iRBCs) in the placenta (2–4). During Plasmodium
falciparum infection, VAR2CSA, a member of the Plasmodium
falciparum erythrocyte membrane protein 1 (PfEMP1) family (5–
8), which interacts with chondroitin sulfate A (CSA) and hyal-
uronic acid (HA) (9, 10), facilitates the sequestration of iRBCs in
the placenta. The increased expression of CSA and HA in placental
tissue promotes iRBC accumulation and interaction between the
parasite and host cells.
The placenta is a unique transient organ responsible for mater-
nal-fetal exchange and functions as an immunologic barrier
against microbial infection, recognizing and responding to patho-
gens via innate pattern recognition receptors (PRRs) and ulti-
mately preventing harmful or detrimental effects on fetal devel-
opment (11, 12). In malaria, it has been demonstrated that
members of the Toll-like receptor (TLR) family recognize com-
ponents of Plasmodium sp. and stimulate an immune response.
For example, studies have shown that glycosylphosphatidylinosi-
tol (GPI) is recognized by TLR2 and TLR4 (13), while the para-
site’s DNA in association with hemozoin, a metabolite derived
from the heme detoxification mechanism in the parasite, has been
implicated in the stimulation of TLR9 (14–16). TLR activation is
mediated by a range of adaptor proteins, such as MyD88, Tirap
(also known as Mal), Trif, and Tram, and culminates in the ex-
pression of proinflammatory genes (17). In acute malaria, TLR9
association with MyD88 is essential for the initiation of an inter-
leukin 12 (IL-12)/gamma interferon (IFN-)-mediated immune
response and the subsequent increased expression of proinflam-
matory cytokines (18).
Polymorphisms in TLRs have been correlated with the severity
of malaria (19–21). More specifically, in pregnant women, these
polymorphisms increase the susceptibility to placental malaria
(19, 21). Innate immune activation during pregnancy has been
associated with a range of complications for the mother and fetus,
such as intrauterine growth restriction, low birth weight, and
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abortion. Several studies have demonstrated that TLRs are pivotal
for the host immune responses to Plasmodium and related patho-
gen-associated molecular patterns (12–15, 22). However, the roles
of these TLRs in Plasmodium-induced pregnancy complications
have not yet been examined. Accordingly, the mechanism that
triggers immune activation following malaria infection during
pregnancy is not well understood. In the present study, using a
mouse model of placental malaria (3) and validating it in mice
with a C57BL/6 genetic background, we analyzed the involvement
of MyD88, an adapter molecule for all TLRs except TLR3 (23), in
the detrimental effects of the severe inflammatory host immune
response to Plasmodium during pregnancy.
MATERIALS AND METHODS
Mice and parasites. C57BL/6 (wild-type [WT]) and MyD88/ mice
from the animal breeding facility of the Institute of Biomedical Sciences at
the University of São Paulo (ICB/USP), aged 8 to 10 weeks, were bred and
maintained with a constant light-dark cycle (12 h/12 h) in conventional
housing at the ICB/USP Department of Parasitology’s animal facility. The
mice received water and were fed with commercial NUVILAB CR-1 feed
(Nuvital, Brazil) ad libitum. Erythrocytes infected with Plasmodium ber-
ghei NK65, constitutively expressing green fluorescent protein (GFP)
(24), were used to induce placental malaria and to conduct in vitro exper-
iments. Infected red blood cells (iRBCs) to be used in experimental infec-
tions were obtained through in vivo passaging in C57BL/6 mice when the
percentage of iRBCs reached approximately 10%. Infection was moni-
tored daily, and parasitemia was assessed in blood smears stained with
Giemsa, followed by counting under a microscope. All procedures were
performed in accordance with the national guidelines on animal welfare
and were authorized by the ethics committee at ICB/USP under protocol
number 065fls104livro2.
Synchronization and enrichment of parasitized erythrocytes. To
obtain mature forms of the parasite (i.e., trophozoites and schizonts),
iRBCs were synchronized as described previously (25). Briefly, iRBCs
were collected from infected WT mice exhibiting 10 to 20% parasitemia
through cardiac puncture and transferred to RPMI 1640 culture medium
(Gibco, Life Technologies, Paisley, Scotland) supplemented with 25% fe-
tal bovine serum (FBS). The iRBCs were subsequently maintained in vitro
at 37°C for 14 h in an atmosphere containing 5% CO2, 85% N2, and 10%
O2. The parasitized erythrocytes were then enriched using a magnetic
separation column (Miltenyi Biotec, Bergisch Gladbach, Germany) to
generate cell populations consisting of approximately 95% iRBCs, as as-
sessed by thick blood smears.
Cytoadherence assays. To confirm the ability of P. berghei NK65GFP-
infected erythrocytes to bind to specific receptors, the iRBCs were en-
riched, synchronized, and coincubated with CHO cells stably expressing
chondroitin sulfate A (CSA) (CHO-K1 cells) for 1 h at 37°C in an incu-
bator with 5% CO2. For inhibition assays, following the first incubation
period, nonadherent cells were removed by washing 3 times, and the cells
were then incubated for 20 min in the presence of increasing doses of
soluble CSA, chondroitin sulfate B (CSB), or colominic acid (CA) (3).
Following a final wash, the cultures were fixed and stained using the In-
stant-Prov kit for differential staining (New Prov, Brazil). Cytoadherence
was determined by counting the number of iRBCs attached per CHO cell.
Ex vivo adherence of the iRBCs to placental tissue was achieved using
placentas from uninfected females, obtained at G19 and treated as de-
scribed previously (26). Briefly, the placentas were fixed in 2% formalin
and 0.5% glutaraldehyde for 10 min, heated in a microwave oven prior to
paraffin embedment, cut into 5-m sections, and placed on glass slides.
This fixation protocol preserves the binding capacity of the glycosylami-
noglycans (GAG) in the placental intervillous spaces. Following deparaf-
finization and rehydration, the boundaries of tissue sections were delim-
ited using a Dako pen. For iRBC ligand blocking experiments,
synchronized iRBCs were preincubated with the indicated concentrations
of CSA, CSB, or colominic acid from bovine trachea (Sigma) at 37°C for
30 min with moderate agitation. After being washed, the iRBCs were used
to overlay the placental sections as described above. The slides were
mounted using Vectashield (Vector Laboratories, Inc., Burlingame, CA)
and examined by fluorescence microscopy. The number of iRBCs (green
dots) adhering to the placental sections under each experimental condi-
tion was determined in a blinded fashion, using the cell count plugin from
Image J Software, and 50 fields were counted in each of 3 independent
experiments.
Pregnancy monitoring and experimental infection. Detection of a
vaginal plug and measurement of body weight were used in combination
to determine the gestation time, as described previously (27). Females (2
or 3) were placed with one male for 24 h and then examined for the
presence of a vaginal plug. The day the vaginal plug was detected was
considered the first day of gestation (G1). The progression of pregnancy
was monitored every other day based on weight gain. Successful fertiliza-
tion was confirmed between G8 and G10 when the females exhibited an
average increase of 3 to 4 g in body weight. Therefore, weight gain was
taken as an indication of pregnancy, whereas abrupt weight loss was in-
terpreted as an indicator of pregnancy complications or interruption.
Pregnant mice were infected intravenously (i.v.) on G13 with 1  105
iRBCs, and parasitemia was assessed daily. G13 was determined as the
optimal time point for infection to allow analysis of the pathological fea-
tures of malaria during the course of pregnancy and in the developing
fetus, because infection at an earlier stage did not allow the pregnancy to
reach term, which is consistent with previous reports (28–30). The preg-
nant mice underwent cesarean sections on G19, and their placentas were
collected for histopathological analysis and RNA extraction. Nonpreg-
nant infected females or noninfected pregnant females were used as con-
trols when appropriate. To monitor the offspring, foster mothers were
employed in postnatal follow-up analyses of the newborns to avoid weight
bias caused by differential maternal nourishment. To evaluate maternal
care in relation to infection, we monitored the offspring for 30 days after
birth. To construct the survival rate, we did not distinguish the cause of
death of the pups (as infanticide or cannibalism).
Collection of placentas. The placentas from the infected and nonin-
fected females were treated in a similar manner. The placentas were di-
vided into two parts: one half was fixed in 1.6% paraformaldehyde with
20% sucrose for further processing, and the other half was collected for
RNA extraction. Paraffin-embedded, nonconsecutive placental sections
were stained with hematoxylin-eosin (H&E), periodic acid-Schiff (PAS),
or picrosirius red and then examined under a conventional Zeiss micro-
scope (Axio imager M2) coupled with a Zeiss camera (Axio Cam HRc).
For histological and morphometric analyses, the placental sections were
coded and examined by two different individuals in a blinded fashion.
Morphometric analysis. Morphometric analyses of the placentas
were performed as described previously (3). Briefly, the vascular space was
quantified through analysis of hematoxylin-eosin (H&E)-stained sections
of the placentas. For each section, three areas of the intervillous space were
randomly selected for image acquisition (magnification, 200) using a
Zeiss color camera (Axio Cam HRc) connected to a Zeiss light microscope
(Axio Imager M2). The images were analyzed using Image J software
(http://rsbweb.nih.gov/ij/). Briefly, the images were subjected to an auto-
mated light analysis procedure in which noise removal was applied to
ensure color and image quality standardization across the sections and
specimens. A color threshold was applied to the images to cover the area
corresponding to the blood space lumen. The percentage of coverage was
calculated as the ratio between the number of pixels covered by the area
defined by the threshold and the total number of pixels in the image. The
blood vascular area in each placenta was estimated based on the analysis of
three nonconsecutive sections.
Gene expression analysis via qRT-PCR. RNA was extracted from the
placenta obtained at G19 (6th day postinfection) samples using the
RNeasy minikit (Qiagen) in accordance with the manufacturer’s protocol
for animal tissue (Animal Cell 1). Total RNA (1 g) was converted into
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cDNA (First Strand cDNA Synthesis Transcriptor kit; Roche, Penzberg,
Germany) using random hexamer primers. Relative gene expression was
quantified via quantitative reverse transcription-PCR (qRT-PCR) using
TaqMan assays (Applied Biosystems) with probes specific for IL-6
(Mm00446190_m1), gamma interferon-induced protein 10 (IP-10)
(CXCL10; Mm00445235_m1), and tumor necrosis factor alpha (TNF-)
(Mm00443258_m1). Briefly, 1.25 l of 20 target assay and 1.25 l of
20 mouse GAPD (Applied Biosystems) mix was added to 12.5 l of
MasterMix (Applied Biosystems), 5 l of deionized distilled water, and
100 ng of cDNA. All experiments were carried out in duplicate. The ther-
mal cycler conditions were 50°C for 2 min, 95°C for 10 min, and then 40
cycles of 95°C for 15 s and 60°C for 1 min. The data were normalized
according to the constitutive expression of the GAPDH gene, and the
2CT method was applied for quantification (31).
Cytokine measurements. IL-6, TNF-, IFN-, and IL-10 production
was evaluated in serum samples from the pregnant mice obtained at G19
(6th day postinfection) using cytometric bead arrays. This procedure was
performed in accordance with the manufacturer’s instructions (cytomet-
ric bead arrays [CBA]; BD Biosciences). The serum samples were analyzed
in a FACS Canto II flow cytometer (BD Biosciences) using the supplied
cytometer setup beads and FCAP software (BD Biosciences).
Statistical analysis. Significant differences between the groups were
evaluated via analysis of variance (ANOVA) following Bonferroni’s post-
test. Survival rates were analyzed using the log rank test. The statistical
tests were performed with GraphPad Prism version 5.0 software (Graph-
Pad Software, San Diego, CA).P values of0.05,0.01, and0.001 were
considered statistically significant.
RESULTS
P. berghei NK65GFP-iRBCs adhere to placental tissue via CSA
and could be related to the placentalmalaria.Adhesion of iRBCs
to placental tissue may be detrimental to pregnancy and fetal de-
velopment. In P. falciparum infections, parasite adhesion to pla-
cental tissue is mediated by CSA (9, 32). Similar results were ob-
tained in a murine model using P. berghei ANKAGFP in BALB/c
mice (3). P. berghei ANKAGFP infection normally kills C57BL/6
mice after 1 week of infection due to neurological complications
and is therefore characterized as an experimental model of cere-
bral malaria. Thus, to allow the use of knockout mice together
with C57BL/6 background mice, we established a new mouse
model of placental malaria using a parasite strain (P. berghei
NK65GFP) that does not cause cerebral malaria (33). In our model,
pregnant mice were infected on gestational day 13 (G13) and
killed at G19 to allow us to obtain intact placentas (see Fig. S1 in
the supplemental material).
Initially, to validate our model, we evaluated the alterations
induced in the placental tissue by parasite infection. Our results
showed that at G19, placentas from C57BL/6 mice infected with P.
berghei NK65GFP exhibited increased tissue disorganization com-
pared to placentas from noninfected mice (Fig. 1A versus B), col-
lagen deposition in the labyrinth zone (Fig. 1C and D), and ne-
crotic areas between the spongiotrophoblast and decidua (Fig.
1E). Moreover, these events appear to be related to the presence of
iRBCs in the syncytiotrophoblast (Fig. 1F).
Next, to determine whether P. berghei NK65GFP-iRBCs have
the capacity to adhere to CSA, we evaluated the effect of CSA on
the adhesion of synchronized mature iRBCs to CHO-K1 cells ex-
hibiting a high level of surface expression of CSA. Figure 2A shows
that CSA, but not CSB or CA, competitively inhibited iRBC adhe-
sion in a dose-dependent manner. Finally, through a series of ex
vivo adhesion assays, we demonstrated that P. berghei NK65GFP-
iRBCs adhered to the placental tissue (Fig. 2B and C). Together,
these results validate our model of placental malaria.
The increased parasitemia resulting from pregnancy is not
dependent on MyD88 activation. Next, to determine the role of
MyD88 in the increased susceptibility to malaria observed during
pregnancy, a phenomenon previously observed in P. berghei
ANKAGFP-infected BALB/c mice (32, 34), we analyzed para-
sitemia on the 6th day postinfection. Our results showed that both
MyD88/ and WT (C57BL/6 background) pregnant mice exhib-
ited higher parasitemia levels than nonpregnant mice (Fig. 3).
Placental pathology is associated with the activation of the
MyD88 adaptor protein pathway.The characteristics of placental
malaria include changes in tissue organization and a reduction of
the vascular space (35). As described previously for other strains
(34), placentas from infected C57BL/6 mice exhibited a reduction
in the vascular space due to malaria infection compared to placen-
tas from noninfected mice (Fig. 4A). Using a morphometric
method to quantify the area of blood sinusoids in cross sections of
the placentas, we observed a reduction in the area of blood sinu-
soids in the infected WT pregnant mice compared to the nonin-
FIG 1 P. berghei NK65GFP induces placental malaria. Pregnant WT females
were infected i.v. with 1  105 P. berghei NK65GFP iRBCs on the 13th gesta-
tional day. (A and B) Photomicrographs of the sinusoidal areas of placentas
from noninfected (A) and infected (B) mice stained with PAS, showing the
tissue organization and vascular space. (C and D) Collagen fibers were stained
with picrosirius red and visualized via conventional light microscopy (C) and
polarization light microscopy (D). (E) Necrotic areas were stained with H&E.
(F) iRBCs are present in the syncytiotrophoblast. The arrows indicate necrosis
in panel B, collagen in panels C and D, and iRBCs in panel F. De, decidua; St,
spongiotrophoblast; Ne, necrosis; La, labyrinth zone. Magnification,400 (A
to E) and1,000 (F).
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fected WT pregnant mice (48.13% 	 0.88% versus 39.44% 	
0.64%; mean 	 standard error [SE]) of the vascular space in the
noninfected and infected mice, respectively;P 0.001). However,
when the analysis was conducted in placentas from MyD88/
pregnant mice, no differences were observed between the infected
and noninfected groups (Fig. 4B).
Next, to evaluate the influence of the reduction of vascular
space on fetal development, we analyzed fetus weight on day G19.
Figure 4C illustrates the sizes of the 21-day-old mice born to a
noninfected mother (left) and an infected mother (right). Consistent
with previous studies, the fetuses from infected WT mice displayed a
30% reduction in body weight compared to fetuses from noninfected
WT mice (Fig. 4C). However, the fetuses from infected MyD88/
did not exhibit significant differences in body weight compared to
those from their noninfected counterparts (Fig. 4D).
Because infection with P. berghei NK65GFP did not result in
placental pathology in MyD88/ mice, we hypothesized that the
MyD88-mediated inflammatory response might be involved in
this process. Therefore, we investigated the cytokine profiles in the
serum and the placenta tissue of WT and MyD88/ pregnant
mice following P. berghei NK65GFP infection. When the infected
groups were compared, the WT mice showed higher serum levels
of IL-6, IFN-, and TNF- (Fig. 5A, B, and C). In addition, IL-10
FIG 2 P. berghei NK65GFP adheres to placental tissue via CSA, inducing placental malaria. (A) Competition assay of iRBCs binding to CHO-K1 cells preincu-
bated with increasing concentrations of CSA, CSB, and CA. The numbers of iRBCs in 10 randomly selected fields were counted, and the values presented are mean
percentages of binding compared to the control. (B) Ex vivo adhesion assay in placental tissue from noninfected mice. iRBCs were preincubated with increasing
concentrations of CSA and used in the binding assays as described in Materials and Methods. The data are the proportion of bound iRBCs, expressed as a
percentage of the control. (C) Typical microscopic image obtained from adherence assays, showing iRBCs adhering to the syncytiotrophoblast cell layer (left).
Representative images from adherence-blocking assays, in which the iRBCs were preincubated with 100 g/ml (middle) or 1,000 g/ml (right) of CSA. All data
are the means	 SE and are representative of three independent experiments (n
 3). **, P 0.01; ***, P 0.001.
FIG 3 Pregnancy influences parasitemia levels. Pregnant WT and MyD88/
mice were infected intravenously on G13 with 1  105 P. berghei NK65GFP
iRBCs. As a control, nonpregnant mice were infected in parallel. The animals
were killed 6 days postinfection. Data are means	 SE (10 mice/group). *, P
0.05 compared with nonpregnant WT mice; #, P 0.05 compared with non-
pregnant MyD88/ mice.
Mouse Placental Malaria Development Is MyD88 Dependent
February 2014 Volume 82 Number 2 iai.asm.org 833
serum levels were significantly reduced in MyD88/ mice com-
pared to WT mice, in both the infected and noninfected groups
(Fig. 5D). Regarding the proinflammatory markers examined in
the placental tissue, we observed increased expression of TNF-,
IP-10, and IL-6 only in infected WT mice compared to nonin-
fected WT (Fig. 6). In addition, we did not observe differences
between infected and noninfected MyD88/ mice.
Finally, to evaluate the effects of maternal infection in the prog-
eny, we followed the pups’ survival for 30 days after parturition.
Analysis of the survival rates of the pups indicated an interesting
phenomenon regarding maternal care. The results presented in
Fig. 7 show that infected WT mothers displayed decrements in
maternal care that influenced the pup survival rate. Surprisingly,
however, pups from infected MyD88-deficient mothers exhibited
better survival rates than pups from infected WT mothers.
DISCUSSION
Placental malaria is a major issue in many regions where malaria is
endemic, and the immunological mechanisms that play a role in
the evolution of this outcome are still not completely understood.
It is well established that in humans, accumulation of P. falcipa-
rum-iRBCs in the placenta occurs through the adhesion of
PfEMP-1 to CSA, leading to malaria pathogenesis during preg-
nancy (2, 5, 36). However, this characteristic is not exclusive to P.
falciparum. Using a murine model of placental malaria, our group
and others have demonstrated the ability of P. berghei ANKA to
adhere to placental tissue (37). In addition,Plasmodium chabaudi-
and Plasmodium yoelii-iRBCs have been reported to accumulate
in the placenta (4, 38, 39). To evaluate the involvement of the
MyD88 adapter protein in placental malaria, we first validated the
P. berghei variant NK65GFP as a potential model for this compli-
cation, inasmuch as this parasite, in contrast to P. berghei ANKA,
does not induce cerebral malaria in mice with a C57BL/6 back-
ground. Through in vitro and ex vivo experiments, we demon-
strated that the membrane components of the P. berghei NK65GFP
iRBCs adhered to CSA on the surface of the chondroitin sulfate
A-expressing CHO-K1 cell line and to placental tissue.
FIG 4 MyD88 signaling is associated with a diminished vascular placental space and reduced growth rate in the progeny of infected mothers. Pregnant WT and
MyD88/ females were infected i.v. with 1  105 P. berghei NK65GFP iRBCs on the 13th gestational day. (A) Representative images of the sinusoidal areas of
placentas from noninfected (left) and infected (right) mice. (B) The sinusoidal areas of the placentas were quantified relative to the total area of the placenta using
an automated method of morphometric analysis. (C) Images of mice at 21 days of age from noninfected (left) and infected (right) mothers. (D) Fetal body weights
in noninfected and infected mothers at G19 at the time of cesarean section. Data are presented as a scatter plot, with the medians indicated (15 to 40 mice/group).
***, P 0.001.
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Using this infection model, we showed that P. berghei
NK65GFP-induced activation of the innate immune system via the
MyD88 pathway is clearly involved in the development of PM.
Moreover, because P. berghei NK65GFP-infected MyD88/ preg-
nant mice do not show an increase in proinflammatory cytokines
in the serum and placenta that correlates with the reduced placen-
tal vascular space observed in infected WT pregnant mice, our
results indicate that PM development occurs because of excessive
TLR-induced local inflammation.
These findings show potential significance in relation to ma-
laria during pregnancy and directional cytokine release by the pla-
centa, suggesting that TLRs may act as a placental tissue sensor of
Plasmodium components that, through the MyD88 pathway, trig-
ger the release of inflammatory cytokines into the maternal blood.
Inflammation as a result of innate immune system activation
via TLRs has a negative effect on the outcome of pregnancy (40).
In rats, intraperitoneal administration of LPS, the best-described
TLR4 agonist, during pregnancy increases the concentrations of
TNF- and IL-6 in maternal serum as well as the placental expres-
sion of TNF-, IL-6, and IL-1 (40). Moreover, LPS from Gram-
negative bacteria has been implicated in preterm delivery (41).
TLR3 activation via poly(I·C), a synthetic double-stranded RNA
that mimics viral RNA, during late pregnancy also has a negative
effect on pregnancy (42). However, TLR2 activation does not ap-
FIG5 MyD88 is involved in the induction of systemic proinflammatory cytokines in pregnant mice. (A to D) Serum cytokine production of IL-6, TNF-, IFN-,
and IL-10 measured via cytometric bead arrays (CBA). Serum samples were obtained at G19 (6th day postinfection). Data are means	 SE (5 mice/group). *,
P 0.05, ***, P 0.001.
FIG 6 Placental pathology is associated with altered gene expression of inflammation markers. Placental gene expression was quantified for TNF- (A), gamma
interferon-induced protein 10 (IP-10) (B), and IL-6 (C). mRNA expression was measured in placentas from WT and MyD88/ mice that were either infected
with P. berghei NK65GFP (hatched bars) or not infected (open bars). Relative quantification was performed via normalization to GAPDH expression levels.
Samples were obtained at G19 (6th day postinfection). The results are plotted as the fold change over noninfected WT mice, and each bar represents the mean	
SE (5 placentas/group from different donors). *, P 0.01; ***, P 0.001.
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pear to be related to inflammatory responses in placental tissue.
TLR stimulation is also known to induce fetal reabsorption (43)
and preeclampsia (44). In addition, clinical studies have linked
TLR activation to pregnancy disorders such as preterm labor, pre-
eclampsia, and intrauterine growth restriction (IUGR) (12).
A consequence of TLR activation is the production of proin-
flammatory cytokines. In infected pregnant women, it has been
shown that the soluble levels of TNF receptors are correlated with
P. falciparum parasitemia (45). Moreover, systemic production of
TNF- has been observed following malaria infection during
pregnancy and has been found to be associated with maternal
anemia and low birth weight. In addition to TNF-, other proin-
flammatory cytokines, such as IFN-, have been implicated in
spontaneous abortion in humans (46). Similarly, murine models
developed in an attempt to induce pregnancy failure through ma-
laria infection point to systemic increases in TNF- and IFN-
production as a cause of abortions (47, 48). In our model system,
we did not observe an increase in abortion or reabsorption due to
systemic TNF- or IFN- production. However, our results indi-
cated that the production of these cytokines in WT infected mice
was clearly associated with the observed placental impairment
(i.e., inflammation, tissue disorganization, and reduction of vas-
cular space). A possible explanation for the absence of abortions in
this study may be the time of infection, which, in contrast to pre-
vious studies (47), was chosen to allow the pregnancies to reach
term in our murine model (3). In addition to the systemic mater-
nal levels of TNF-, the placentas from the infected WT mice
showed increased expression of TNF- mRNA. Interestingly,
both systemically and locally, the increase in proinflammatory
cytokines was dependent on MyD88 expression, suggesting that
the absence of this adaptor protein may have a negative effect on
the immune response. In this regard, Franklin and collaborators
showed that MyD88 is essential for eliciting TNF- and IFN-
production during infection with P. chabaudi (49). In addition,
those authors showed that in the absence of MyD88 expression,
mice exhibited an attenuated pathology.
Malaria infection during pregnancy is associated with altera-
tions in placental structure that result in insufficient gas exchange
and reduced nutrient availability, leading to impaired fetal growth
and development (35, 50, 51). In this regard, murine models have
been useful for investigating the causes and consequences of pla-
cental modifications. Working with BALB/c mice, we previously
demonstrated that pregnant mice are more susceptible to malaria
infection than nonpregnant mice (52). In this study, we showed
that infected C57BL/6 mice also exhibited increased susceptibility
to malaria infection by P. berghei. Another primary finding of this
study was that fetuses from the infected WT mice had lower body
weights than the controls, which is consistent with the symptoms
of infection observed in pregnant women. Additionally, the exper-
iments in knockout mice demonstrated a clear correlation be-
tween reduced weight and the expression of MyD88. In the ab-
sence of this protein, a reduction of placental inflammation was
observed, and fetal weight was therefore not affected. Consistent
with this observation, using a model of preterm delivery induced
by Escherichia coli infection, Filipovich and collaborators demon-
strated that MyD88-deficient mice were protected from preterm
delivery induced by bacterial infection compared to WT mice
(53). Notably, although the MyD88-deficient mice were able to
produce TNF- in response to bacterial infection, the production
of this cytokine was lower than in WT mice and was correlated
with delayed TRIF signaling.
Infected animals display a range of characteristics, including
anorexia, adipsia, lethargy, and reduced social interaction (54),
which are referred to as sickness behavior and represent an adap-
tive strategy to aid the organism in recovery from infection (55).
Using a model of infection, Weil and collaborators showed that
mice injected with LPS exhibited a decrement of maternal care,
and their litters were therefore not able to maintain normal
growth (55). In the present work, we observed that infected WT
mothers also exhibited impaired maternal care, showing increased
infanticide and cannibalism events. In eutherian mammals, there
is a major expenditure of energy during the reproductive cycle due
to lactation. For this reason, infanticide and cannibalism in ro-
dents could be explained as a mechanism to prevent the waste of
additional investments in infants (56). This behavior could be the
result of stress induced by infection. In this regard, similar behav-
ior has been observed in rodents deprived of food (57). Surpris-
ingly however, the MyD88-deficient mice exhibited delayed and
attenuated infanticide and cannibalism events.
Studies characterizing the pathogenesis of PM are useful for
the development of therapeutic strategies. As a continuation of
our previous findings, in this study, we identified a key pathway
stimulated by the parasites that triggers the innate immune sys-
tem, leading to a local inflammatory response. This process cul-
minated in the placental pathology observed in the infected mice
and, ultimately, reduced fetal body weight. In conclusion, this
study illustrates the importance of a severe local inflammatory
response in the pathogenesis of PM via MyD88 signaling. Conse-
quently, blocking this pathway may become a critical approach for
the treatment of placental inflammation induced by Plasmodium.
The combination of blocking innate immune receptors or pro-
teins related to the activation of these receptors and concomitant
use of antiplasmodial drugs is the keystone of our conceptual
model for investigating novel interventional strategies for treating
malaria in pregnancy.
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